Price Alert

AN2 Therapeutics Inc. (ANTX)

NASDAQ: ANTX · Real-Time Price · USD

1.10

0.05 (4.27%)

At close: Aug 15, 2025, 3:59 PM

1.11

0.78%

After-hours: Aug 15, 2025, 07:15 PM EDT

AN2 Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Mar 31, 2021
Cash & Equivalents	18.22M	19.98M	21.35M	33.5M	26.77M	24.69M	15.65M	32.62M	40.81M	26.71M	27.22M	28.8M	40.62M	82.52M	12.1M	-4.07M
Short-Term Investments	44.7M	47.08M	62.27M	59.92M	77.77M	89.52M	91.65M	91.2M	54.45M	61.81M	68.84M	75.58M	72.77M	35.84M	46.46M	8.14M
Long-Term Investments	8.3M	11.48M	5.02M	n/a	n/a	3.9M	27.19M	26.36M	n/a	n/a	3.22M	1.99M	2.42M	n/a	3.49M	n/a
Other Long-Term Assets	n/a	304K	804K	n/a	1.04M	1.04M	1.04M	1.04M	707K	734K	667K	647K	707K	688K	1.72M	-4.07M
Receivables	2.7M	300K	300K	1M	300K	500K	1.4M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	1.91M	2.2M	2.34M	3.26M	2.6M	-500K	n/a	2.59M	2.95M	1.8M	2.56M	2.91M	3.49M	1.43M	n/a	n/a
Total Current Assets	67.52M	69.56M	86.26M	97.69M	107.44M	116.31M	110.51M	126.41M	98.21M	90.32M	98.62M	107.3M	116.88M	119.78M	60.11M	4.07M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	13K	34K	53K	73K	13K	32K	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	8.3M	11.78M	5.83M	n/a	1.04M	4.95M	28.24M	27.4M	720K	768K	3.94M	2.71M	3.14M	720K	5.21M	-4.07M
Total Assets	75.83M	81.34M	92.09M	97.69M	108.48M	121.26M	138.74M	153.81M	98.93M	91.08M	102.56M	110.01M	120.02M	120.5M	65.32M	n/a
Account Payables	2.11M	3.07M	3.32M	1.71M	1.89M	2.43M	2.68M	4.88M	3.13M	3.54M	2.12M	1.44M	1.61M	2.61M	1.06M	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	8.01M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	13K	34K	n/a	73K	13K	32K	n/a	n/a
Other Current Liabilities	-1.2M	898K	2.47M	3.38M	6.4M	321K	668K	976K	1.56M	712K	6K	1.74M	709K	1.13M	330K	n/a
Total Current Liabilities	2.11M	8.01M	10.24M	10.02M	10.13M	10.66M	14.04M	14.84M	11.16M	8.57M	7.19M	4.43M	4.15M	5.09M	3.4M	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	4.87M	4.94M	n/a	n/a	n/a	n/a	n/a	n/a	1K	1K	2K	3K	4K	6K	109.33M	n/a
Total Long-Term Liabilities	4.87M	4.94M	n/a	n/a	n/a	8.23M	n/a	n/a	1K	1K	2K	3K	4K	6K	109.33M	n/a
Total Liabilities	6.98M	8.01M	10.24M	10.02M	10.13M	10.66M	14.04M	14.84M	11.16M	8.57M	7.19M	4.43M	4.15M	5.09M	112.73M	n/a
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	13K	34K	53K	73K	13K	32K	n/a	n/a
Common Stock	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Retained Earnings	-222.89M	-216.43M	-205.78M	-198.25M	-185.51M	-171.07M	-154.46M	-137.56M	-120.85M	-105.05M	-89.72M	-77.88M	-66.54M	-56.42M	-47.38M	n/a
Comprehensive Income	25K	48K	31K	112K	-27K	53K	275K	-122K	-119K	-175K	-374K	-541K	-360K	-158K	-27K	-20.32M
Shareholders Equity	68.84M	73.33M	81.85M	87.67M	98.35M	110.6M	124.7M	138.97M	87.76M	82.52M	95.37M	105.57M	115.86M	115.41M	-47.41M	2.75M
Total Investments	53M	58.55M	67.29M	59.92M	77.77M	93.42M	118.84M	117.56M	54.45M	61.81M	72.06M	77.57M	75.19M	35.84M	49.94M	8.14M